Company Update2 Min Read InvestyWise NewsonNovember 4, 2026 KIMS Hospitals confirms NIL deviation in QIP fund utilization for September 2026 quarter Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has officially confirmed that there was NIL deviation or variation in the…
Company Update2 Min Read InvestyWise NewsonNovember 4, 2026 KIMS Hospitals confirms NIL deviation in warrant fund utilization for Q2 2026 Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has confirmed NIL deviation or variation in the utilization of funds raised…
Company Update1 Min Read InvestyWise NewsonNovember 4, 2026 Websol Energy confirms no deviation in fund utilisation for Q2 FY27 Websol Energy System Limited has submitted its Statement of Deviation or Variation for the quarter ended September 30, 2026. The company…
Board Meeting2 Min Read InvestyWise NewsonNovember 4, 2026 Lohia Corp approves financial results and accepts director resignation Lohia Corp Limited’s Board of Directors convened on November 4, 2026, to approve the unaudited standalone and consolidated financial…
Company Update2 Min Read InvestyWise NewsonNovember 4, 2026 Gallantt Ispat announces promoter group share transfer of 3.316% Gallantt Ispat Limited has announced an inter-se transfer of shares within its promoter group. Dinesh R. Agarwal will transfer 80,00,000…
Company Results2 Min Read InvestyWise NewsonNovember 4, 2026 Augmont Enterprises approves Q2 FY27 unaudited financial results Augmont Enterprises Limited’s Board of Directors, in a meeting held on November 4, 2026, approved the unaudited standalone and…
Company Update2 Min Read InvestyWise NewsonNovember 4, 2026 KIMS Hospitals reports ₹150 crore raised from warrants in Q2 FY27 Krishna Institute of Medical Sciences Limited (KIMS) has reported raising ₹150 crore as upfront warrant subscription money during the second…
Company Update3 Min Read InvestyWise NewsonNovember 4, 2026 Balkrishna Industries Ltd. outlines growth roadmap and FY27 highlights Balkrishna Industries Ltd. (BKT) has presented its growth roadmap, detailing ambitious revenue targets by 2030 and highlighting key…
Board Meeting2 Min Read InvestyWise NewsonNovember 4, 2026 Augmont Enterprises Limited reports Q2 FY27 results and approves ESOP plan Augmont Enterprises Limited has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended…
Company Results3 Min Read InvestyWise NewsonNovember 4, 2026 Aurobindo Pharma declares 700% interim dividend of Rs 7 per share Aurobindo Pharma Limited announced a significant development post its Board of Directors meeting held on November 4, 2026. The company has…